Neuraptive Therapeutics, Inc. 보도자료 - 뉴스와이어

Neuraptive Therapeutics, Inc. 보도자료

Neuraptive Therapeutics, Inc. 보도자료

로버트 R. 루폴로 박사: 2022년 11월 18일 15:30; Neuraptive Therapeutics, Inc.

“The NEUROFUSE Study has yielded promising early clinical results consistent with preclinical studie

“The NEUROFUSE Study has yielded promising early clinical results consistent with preclinical studies of NTX-001,” said Evan Tzanis, Chief Operating Officer and EVP of R&D at Neuraptive Therapeutics, Inc. (Photo: Business Wire): 2024년 1월 10일 13:20; Neuraptive Therapeutics, Inc.

Evan L. Tzanis, COO and EVP Head of R&D, Neuraptive Therapeutics, Inc. (Photo: Business Wire)

Evan L. Tzanis, COO and EVP Head of R&D, Neuraptive Therapeutics, Inc. (Photo: Business Wire): 2024년 3월 14일 11:20; Neuraptive Therapeutics, Inc.

Evan L. Tzanis, Chief Operating Officer and EVP of R&D, Neuraptive Therapeutics, Inc. (Photo: Busine

Evan L. Tzanis, Chief Operating Officer and EVP of R&D, Neuraptive Therapeutics, Inc. (Photo: Business Wire): 2024년 9월 13일 13:40; Neuraptive Therapeutics, Inc.

David M. Brogan, MD, MSc, Assistant Professor, Orthopaedic Surgery, Division of Hand and Microsurger

David M. Brogan, MD, MSc, Assistant Professor, Orthopaedic Surgery, Division of Hand and Microsurgery, Washington University in St. Louis (Photo: Business Wire): 2024년 9월 20일 17:00; Neuraptive Therapeutics, Inc.

메뉴 닫기